← Leaderboards
Alan N. Houghton
Sloan-Kettering Institute For Cancer Res
$9,129,158
Attributed
$9,592,868
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–12$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$25,042,488 · 10
By mechanism
P01$19,666,652 · 7
R01$3,611,740 · 1
T32$1,044,678 · 1
P30$719,418 · 1
Top collaborators
- Jedd D. Wolchok3 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Nai-Kong V Cheung$9,578,208
- David A Scheinberg$21,198,583
- Barrie R Cassileth$4,322,812
- Steven M Larson$7,955,537
- Kenneth J Marians$27,560,768
Others in their field
Top investigators on “Melanoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$206,517,726
- Richard L Schilsky · University Of Chicago$108,377,382
- Larry Arthur$59,113,709
- Charles A Coltman · Southwest Oncology Group$55,198,633
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$47,956,689
- Meenhard Herlyn · University Of Pennsylvania$46,448,742
Research focus
MelanomaClinical ResearchMonophenol MonooxygenaseNeoplasm /Cancer ImmunologyTumor AntigensNeoplasm /Cancer VaccineNeoplasm /Cancer ImmunotherapyHuman SubjectMalignant NeoplasmsImmunityImmuneImmune SystemResponseDifferentiation AntigensAntigensCellsImmunizationT-LymphocyteVaccinesClinical TrialsHuman Therapy EvaluationBaseTumor ImmunityActive Immunization
Grant awards (49)
Immunization Against Melanoma Differentiation Antigens$305,986
R01 · FY2012 · CA
Immunization Against Melanoma Differentiation Antigens$305,986
R01 · FY2011 · CA · contact PI
Genetic Approaches to Immune Adjuvants$344,468
P01 · FY2010 · CA · contact PI
Immunization Against Melanoma Differentiation Antigens$315,449
R01 · FY2010 · CA · contact PI
Administrative Core$452,135
P01 · FY2009 · CA · contact PI
Genetic Approaches to Immune Adjuvants$339,352
P01 · FY2009 · CA · contact PI
Immunization Against Melanoma Differentiation Antigens$294,335
R01 · FY2009 · CA · contact PI
DNA Vaccination Against Melanoma$291,597
P01 · FY2009 · CA · contact PI
Genetic Approaches to Immune Adjuvants$331,108
P01 · FY2008 · CA · contact PI
Immunization Against Melanoma Differentiation Antigens$294,335
R01 · FY2008 · CA · contact PI
Administrative Core$240,657
P01 · FY2008 · CA · contact PI
DNA Vaccination Against Melanoma$156,600
P01 · FY2008 · CA · contact PI
Targeted antigen receptor treatment of cancer$2,150,453
P01 · FY2007 · CA · contact PI
Genetic Approaches to Immune Adjuvants$329,889
P01 · FY2007 · CA · contact PI
Immunization Against Melanoma Differentiation Antigens$294,657
R01 · FY2007 · CA · contact PI
Targeted antigen receptor treatment of cancer$2,174,795
P01 · FY2006 · CA · contact PI
Immunization Against Melanoma Differentiation Antigens$277,892
R01 · FY2006 · CA · contact PI
Genetic Approaches to Immune Adjuvants$163,912
P01 · FY2006 · CA · contact PI
Targeted antigen receptor treatment of cancer$2,046,251
P01 · FY2005 · CA
Immunization Against Melanoma Differentiation Antigens$285,132
R01 · FY2005 · CA
Immunology Research Training$188,052
T32 · FY2005 · CA
BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER$1,889,948
P01 · FY2004 · CA
IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS$262,442
R01 · FY2004 · CA
Immunology Research Training$182,412
T32 · FY2004 · CA
BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER$1,850,521
P01 · FY2003 · CA
IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS$254,800
R01 · FY2003 · CA
Immunology Research Training$198,193
T32 · FY2003 · CA
BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER$1,812,241
P01 · FY2002 · CA
DNA VACCINATION WITH ALTERED ANTIGENS$291,807
P01 · FY2002 · CA
IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS$247,378
R01 · FY2002 · CA
CLINICAL STUDIES/TRIALS$230,631
P01 · FY2002 · CA
Immunology Research Training$173,052
T32 · FY2002 · CA
IMMUNOLOGY$157,506
P30 · FY2002 · CA
DENDRITIC CELLS FOR INDUCTION OF CANCER IMMUNITY$0
P01 · FY2002 · CA
BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER$1,774,569
P01 · FY2001 · CA
DNA VACCINATION WITH ALTERED ANTIGENS$291,807
P01 · FY2001 · CA
IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS$240,172
R01 · FY2001 · CA
CLINICAL STUDIES/TRIALS$230,631
P01 · FY2001 · CA
IMMUNOLOGY$157,506
P30 · FY2001 · CA
IMMUNOLOGY RESEARCH TRAINING$144,406
T32 · FY2001 · CA
DENDRITIC CELLS FOR INDUCTION OF CANCER IMMUNITY$0
P01 · FY2001 · CA
BIOLOGICAL APPROACHES TO THE TREATMENT OF CANCER$1,750,842
P01 · FY2000 · CA
DNA VACCINATION WITH ALTERED ANTIGENS$291,807
P01 · FY2000 · CA
IMMUNOLOGY$246,900
P30 · FY2000 · CA
IMMUNIZATION AGAINST MELANOMA DIFFERENTIATION ANTIGENS$233,176
R01 · FY2000 · CA
CLINICAL STUDIES/TRIALS$230,631
P01 · FY2000 · CA
IMMUNOLOGY RESEARCH TRAINING$158,563
T32 · FY2000 · CA
IMMUNOLOGY$157,506
P30 · FY2000 · CA
DENDRITIC CELLS FOR INDUCTION OF CANCER IMMUNITY$0
P01 · FY2000 · CA